Publication | Open Access
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
92
Citations
34
References
2010
Year
Combination targeting of Dll4/Notch and Ephrin-B2/EphB4 has potential for clinical investigation, providing cumulative efficacy and increased safety over Dll4/Notch inhibition alone.
| Year | Citations | |
|---|---|---|
1995 | 1.8K | |
1985 | 1.3K | |
2010 | 1.3K | |
2003 | 1.2K | |
2003 | 1.2K | |
1999 | 1K | |
2006 | 1K | |
1999 | 987 | |
2006 | 978 | |
2007 | 781 |
Page 1
Page 1